Compositions and methods for immunotherapy
The present invention provides compositions and methods for immunotherapy, which include shelf-stable pharmaceutical compositions for inducing antigen-specific T cells. Such compositions are employed as components of an artificial antigen presenting cell (aAPC), to provide a patient with complexes f...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
01.08.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides compositions and methods for immunotherapy, which include shelf-stable pharmaceutical compositions for inducing antigen-specific T cells. Such compositions are employed as components of an artificial antigen presenting cell (aAPC), to provide a patient with complexes for presentation of an antigen (e.g., a tumor antigen) and/or a T cell co-stimulatory molecule. |
---|---|
Bibliography: | Application Number: US202016821535 |